News10.07.09 07:00 Age: 1 yrs
Ipsogen reports incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer Category: Breast Cancer
 The St Gallen Consensus Meeting specifies that Genomic Grade could be considered as an adjunct to histological gradingIPSOGEN SA (Alternext: ALIPS) today reported that the St. Gallen International Consensus Panel on the Primary Therapy of Early Breast Cancer indicated for the first time that the Genomic Grade could be considered as an adjunct to the histological grade. These new guidelines, published online in Annals of Oncology, represent the consensus opinion of 43 European and US experts on early breast cancer treatment that emerged from the conference which took place in March 2009.  |
|
